Jan-Feb '04 | briefing | mail | don't say this | flakers' jargon | flaker creativity | articles | other places | archives | send mail | ed dewke | legal stuff | order | search | PsorChat | PsorChat Review | 2001 Ed Dewke

Dermacinz in the UK
from Nigel K.

Hi:  Take a look at http://www.dermalogics.co.uk/. This product has received publicity in the UK national newspaper, the Daily Mail. The website doesn't specifically say it’s for psoriasis (says its for dry flaky skin), the article in the Mail suggests it is and contains a purported quote from Gladys Edwards, Chief Exec of the UK Psoriasis Association, who says, She "welcomes products such as these which help to alleviate the disease."

Clinical trials in Ireland apparently showed a 63% success rate with lots of grateful comments — the site says between 60-70% success rate all very nice and vague.  No ingredients are listed.

I have ordered the spray. Do you have any knowledge of the product? -Nigel K.


Ed’s Response: This product is new to me, Nigel.  I went to the site and have these comments....

  • The lack of ingredients disclosure is, to me, a red flag.  The name is compelling:  Dermacinz.  "cinz" is, of course, "zinc" spelled backwards.  There already is (or has been) a product called Dermazinc, which might have compelled these folks to get cutesy with the spelling.  One assumes "zinc" is important in the title because it is the active ingredient.  That was the case for Dermazinc — which was, if I'm not mistaken a lotion.  If this is a zinc based product it would explain some of their claims; e.g., "specific ingredients, which have proved successful in the relief of various skin disorders for over twenty years."  Zinc has been used to treat P for a long, long time.  Perhaps they have been more innovative with the spray-on formulation than they were naming the product.

  • The 60-70% success rate the manufacturer claims is also compelling — not because the odds are so good, but because it would be believable if the product really is zinc-based and if questions were asked of users quickly and infrequently.  "Quickly" because, if topical zinc is going to help P it will probably do so with continuous application inside two weeks.  "Infrequently" because the improvement probably doesn't last long and users are likely develop a resistance to the palliative effects, meaning repeat uses will be less remarkable.

Please let us know what you think about the product (and what you can learn of its ingredients) after you've received it and tried it.  -Ed

This Month's Mail | Archives